Structural and Functional Correlates between HIV-1 and SIV Nef Isolates  by Garcia, J.Victor & Foster, John L.
VIROLOGY 226, 161–166 (1996)
ARTICLE NO. 0642
Structural and Functional Correlates between HIV-1 and SIV Nef Isolates
J. VICTOR GARCIA1 and JOHN L. FOSTER
Department of Virology and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38101
Received August 1, 1996; returned to author for revision September 9, 1996; accepted October 8, 1996
The nef genes of HIV-1 and SIV encode 27–34 kDa myristoylated proteins which have been shown to induce cell surface
CD4 downregulation and bind to a cellular protein kinase. To identify regions of Nef important for function, structure–
function correlates of HIVSF2 nef (Nef) and SIVmm239open nef (SNef) were sought by constructing Nef/SNef hybrids. Metabolic
labeling with 35[S]methionine/cysteine demonstrated similar amounts of 35[S] incorporation into all but one hybrid, SNeftll,
in which the C-terminus of SNef was replaced by that of Nef. The weak protein expression of SNeftll was attributable to
its short half-life of approximately 45 min. Nef, SNef, and SHSNef, a hybrid containing the internal sequences of Nef and
the N- and C-terminal sequences from SNef, downregulated CD4 in human CEM cells. Only Nef and SHSNef downregulated
CD4 in mouse AKR1-G1 cells. Nef, SNef, and SHSNef also effectively bound phosphoproteins of MW  62,000 and 78,000
in CEM cells. Two additional hybrids, in which the Nef sequences of SHSNef were replaced with additional SNef sequences,
were essentially ineffective in both assays. Thus, in two different assays of Nef function, swapping the SIV and HIV internal
nef sequences were shown to be greatly deleterious to Nef function while SHSNef remained functional. q 1996 Academic
Press, Inc.
INTRODUCTION appear to lack a definite fold in the first 70 amino acids
(Lee et al., 1996; Grzesiek et al., 1996). Definable struc-
Human immunodeficiency virus type 1 (HIV-1) is the
ture begins with the (PXX)4 region, and except for a 29causative agent of acquired immune deficiency syn-
amino acid unstructured loop, extends to near the C-
drome (AIDS). Simian immunodeficiency virus (SIV)
terminus. This structurally defined core of Nef (amino
causes a similar syndrome in macaques (Hirsch and
acids 75–207 in HIVSF2Nef) corresponds exactly to a re-Johnson, 1992; Simon et al., 1994). SIV Nef has been
gion of strong homology between HIV and SIV Nefs
shown to be important for virus replication and disease
which suggests that the structured core of Nef contains
progression in vivo (Kestler et al., 1991). In a SCID-hu
the functional domains of the protein. The 3-dimensional
mouse model, HIV-1 Nef has been shown to enhance
structure of SIV Nef remains unknown, but it is likely that
virus replication and pathogenesis (Jamieson et al., 1994;
the regions of SIV Nef that are homologous to HIV Nef
Aldrovandi and Zack, 1996). In vitro, both SIV and HIV
fold into a structure similar to HIV Nef. Like HIV Nefs,
Nefs downregulate surface expression of CD4 and accel-
SIVmm239 Nef has a long segment of amino acids (100)erate total CD4 turnover (Aiken et al., 1994; Anderson et
N-terminal to the putative structured core. In addition,
al., 1994; Benson et al., 1993; Foster et al., 1994; Garcia
SIVmm239 Nef has a 27 amino acid extension at the C-and Miller, 1991; Rhee and Marsh, 1994a and b). The
terminus. We have constructed four HIV/SIV chimeric
mechanism by which Nef downregulates CD4 has not
Nefs to test the functional significance of these structural
been established.
domains of HIV and SIV Nefs in CD4 downregulation and
In immunoprecipitation experiments, HIV and SIV Nefs
association with cellular phosphoproteins.
have been found to associate with two cellular phospho-
proteins (Sawai et al., 1994, 1995). These two proteins
METHODShave been detected by in vitro phosphorylation reactions,
but the significance of the association of Nef with these
Cell lines and culture conditions
phosphoproteins remains undetermined.
Recently, the 3-dimensional structure of a recombinant The human CD4/ T-cell line, CEM, was cultured in
construct of HIV Nef (amino acids 54–205) complexed RPMI with 25 mM HEPES supplemented with 10% fetal
to a SH3 domain has been determined (Lee et al., 1996). bovine serum, penicillin/streptomycin (50 IU/ml and 50
Interestingly, both crystallized Nef and Nef in solution mg/ml, respectively), 2 mM L-glutamine, 1 mM sodium
pyruvate, and maintained at 377 in a humidified incubator
with 5% CO2 . The mouse CD4
/ T-cell line AKR1-G1 was1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (901) 423-2622. E-mail: victor.garcia@stjude.org. maintained in DMEM supplemented with 10% FBS and
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penicillin/streptomycin as previously described (Foster complete RPMI medium for varying lengths of time before
processing for immunoadsorption and SDS–polyacryl-et al., 1994).
amide gel electrophoresis.
Retroviral vectors and producer lines
CD4 cell surface analysisRetroviral vectors for HIVSF2Nef (Nef) and SIVmm239Nef
(SNef) have been previously described (Foster et al., Analysis of cell surface CD4 downregulation was per-
1994). The chimeric construct for SHSNef was made by formed as previously described with PE-labeled mono-
adapting the HIVSF2nef coding sequence to have a 5* clonal antibodies specific for human or mouse CD4 (An-
BglII and a 3* NdeI site corresponding to SIVmm239nef derson et al., 1994; Foster et al., 1994).
sequence by PCR. The BglII/NdeI-digested PCR product
was cloned into the previously described SIVmm239nef mo- In vitro kinase assay
lecular clone (Foster et al., 1994). Chimeric constructs
The association of Nef with putative cellular kinaseswith additional SIV sequence were made by adapting
was determined as described by Sawai et al. (1994).SIVmm239nef coding sequence to have a KpnI site corre-
sponding to HIVSF2nef by PCR. The resulting BglII/KpnI
fragment (SH) and the KpnI/NdeI fragment (HS) were RESULTS
cloned into SHSNef coding sequence. The SNeftll
To study the structure–function relationship between(tailless) construct was made from SIVmm239nef by replac-
HIV and SIV Nefs, four chimeric constructs were madeing coding sequences downstream of the NdeI site with
(Fig. 1). In the resulting chimeric proteins SIVmm239openNefcomplementary oligonucleotides encoding the last 10
(SNef) amino acid sequence was replaced with HIV-1SF2amino acids of HIVSF2nef. All four chimeric coding se-
Nef (Nef) sequence. These proteins are: (1) SHSNef-quences were flanked by EcoRI sites. These EcoRI frag-
(SNef 18–224 replaced by Nef 18–198), (2) SHNef- (SNefments were verified by DNA sequencing and cloned into
110–224 replaced by Nef 82–198), (3) HSNef- (SNef 18–pLXSN (Miller and Rosman, 1989). Amphotropic retrovi-
109 replaced by Nef 18-81), and SNeftll- (SNef 225–262rus producer lines were established as previously de-
replaced by Nef 199–210). The four constructs werescribed (Garcia et al., 1993). Retroviral-mediated gene
cloned into the retroviral vector pLXSN and clonal pro-transfer was performed as previously described (Foster
ducer lines established. The nef genes were then intro-et al., 1994).
duced into the human CEM T-cell line via retrovirus-medi-
ated gene transfer and representative populations estab-Characterization of antibodies
lished. After transduction, mRNA levels were determined
Two polyclonal rabbit sera (one against an Escherichia by Northern analysis and found to be similar for all con-
coli b-galactosidase/SIVmm239Nef fusion protein and the structs (data not shown). To determine the level of protein
other against an SIVmm239Nef peptide consisting of amino expression, immunoprecipitation of metabolically labeled
acids 61–75) from Dr. R. Desrosiers were used to detect extracts were compared (Fig. 2). SNef, Nef, SHSNef,
SNef, SNeftll, and SHNef as previously described (Foster HSNef, and SHNef were all labeled to similar extents in
et al., 1994). These sera were unable to detect Nef and CEM cells (Fig. 2). The levels of the SNeftll hybrid were
the chimeras SHSNef and HSNef. Similarly, a polyclonal found to be low due to its short half-life (Fig. 3). In this
antiserum obtained from Dr. L. Ratner against HIV-1 Nef mutant, the 27 amino acid C-terminal extension of SNef
was able to detect Nef, SHSNef, and HSNef, but not is replaced by the short C-terminal sequence of Nef.
SNef, SNeftll, or SHNef. As a result, immunorecognition These results suggest that the extended C-terminus of
of the six Nefs utilized in this study consisted of an anti- SNef has an important role in maintaining overall protein
SIV group (SNef, SNeftll, and SHNef) and an anti-HIV stability.
group (Nef, SHSNef, and HSNef). To compare the effect of the different hybrids on cell
surface CD4 levels, CEM cells expressing each construct
Metabolic labeling of Nef
were analyzed by flow cytometry (Fig. 4). Only the CEM
cells transduced with the vectors expressing Nef, SNef,CEM or AKR1-G1 cells were split to 0.2 1 106 cells/
ml and grown for 20–28 hr to 0.4–0.5 1 106 cells/ml. The and SHSNef showed reduced levels of surface CD4 ex-
pression (Fig. 4). The HSNef and SHNef hybrids did notcells (2.51 106 cells for each sample) were metabolically
labeled, immunoabsorbed, and analyzed by SDS–poly- affect cell surface CD4 expression (Fig. 4).
Nef downregulates mouse CD4, but SNef does notacrylamide gel electrophoresis as previously described
(Luo et al., 1996). (Garcia et al., 1993; Foster et al., 1994). To determine if
the hybrid proteins exhibited different phenotypes inTo determine the metabolic half-life of SNef and the
SNeftll hybrid proteins cells were labeled as above, mouse cells we performed the experiments described
above in mouse AKR1-G1 cells. As observed for CEMwashed in complete RPMI medium, and incubated in
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FIG. 1. Diagrammatic representation of SIV and HIV Nefs and their chimeras. Amino acid sequences of SIV(black), HIV (white), and SIV/HIV
chimeric proteins are aligned. SNef- SIVmm239openNef, Nef- HIVSF2Nef, SHS- SIVmm239openNef with amino acids 18–224 replaced by HIVSF2Nef amino
acids 18–198, SNeftll- SIVmm239openNef with amino acids 225–262 replaced by HIVSF2Nef amino acids 199–210, SH- SIVmm239openNef with amino acids
110 –224 replaced by HIVSF2Nef amino acids 82–198, HS-SIVmm239open Nef with amino acids 18–109 replaced by HIVSF2Nef amino acids 18–81.
cells SNef, Nef, SHSNef, HSNef, and SHNef were meta- HIVSF2Nef and SIVmm239openNef have been found associ-
ated with a putative cellular kinase(s) in Cos and Jurkatbolically labeled to similiar extents in AKR1-G1 cells, and
Nef and SHSNef downregulated CD4 while HSNef and cells (Sawai et al., 1994, 1995). To determine if the Nef/
SHNef did not (data not shown). As previously reported,
SNef did not downregulate mouse CD4 (Foster et al.,
1994).
FIG. 2. Metabolic labeling of Nef, SNef, and their chimeras in T-cells.
CEM cells exressing each of the constructs described in Fig. 1 (except
SNeftll) were metabolically labeled with [35S]methionine and cysteine
for 1 hr as described under Methods. Lysates from control cells (LXSN),
and cells expressing Nef, SHSNef, and HSNef were immunoprecipi- FIG. 3. Stability of SNef and SNeftll in human T-cells. CEM cells
expressing SNef and SNeftll were metabolically labeled for 1 hr andtated with rabbit anti-HIV-1 Nef (lanes 1–4). Lysates from control cells
(LXSN) and cells expressing SNef and SHNef were immunoprecipitated then incubated in the presence of complete growth media for 0, 1.5,
3, and 4.5 hr before processing for immunoprecipitation analysis. Thewith rabbit anti-SIV Nef serum (lanes 5–7) and processed as for the
anti-HIV Nef immunoreactive samples. The labeled proteins were de- labeled proteins were detected by autoradiography. The half-life of the
SNeftll protein was approximately 45 min.tected by autoradiography.
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kinase complex was present in CEM cells, immunopre-
cipitates from extracts of control or Nef-expressing CEM
cells were assayed for kinase activity. Immunoprecipi-
tates from Nef-expressing cells show MW  62,000 and
78,000 phosphoproteins which are missing in the immu-
noprecipitate of the control cells (Fig. 5A). These results
were similar to results previously reported by Sawai et
al. (1994, 1995) for Jurkat and Cos cells. The ability of
SNef and the chimeras SHSNef, HSNef, and SHNef to
bind the phosphoproteins was also investigated. Kinase
activity was only found in immunoprecipitates from CEM
cells expressing the SNef and SHSNef (Fig. 5B). These
results suggest that the changes in overall structure in-
troduced into the HS and SH hybrids are sufficient to
prevent the formation of the Nef/kinase complex.
DISCUSSION
Although SNef does not downregulate mouse CD4,
both Nef and SNef downregulate surface expression of
human CD4 in several cell types as well as human CD4
expressed in mouse fibroblasts (Garcia et al., 1993; Fos-
ter et al., 1994). Nef and SNef also bind to MW  62,000
and 78,000 phosphoproteins in mouse and human cells,
respectively (Sawai et al., 1994 and 1995). The conserva-
tion of these functions between Nef and SNef is not
surprising given the conservation of their amino acid se-
quences (Shugars et al., 1994).
The SHSNef hybrid downregulated both mouse and
human CD4 in a manner similar to Nef. This suggests
that both the N- (SNef and Nef amino acids 1–17) and
C- (SNef and Nef amino acids 225–262 and 199–210,
respectively) termini are functionally equivalent and ap-
pears to exclude the possibility that the long C-terminal
tail of SNef blocks the downregulation of mouse CD4.
However, further analysis showed that only the amino
terminus is equivalent in both proteins. The carboxyl ter-
minus of SNef was found to be essential for its stable
expression, and its substitution with the shorter tail of
Nef resulted in a dramatic reduction in the protein’s half-
life. At this juncture it is unclear what structural changes
are responsible for the short half-life of the SNeftll mu-
tant.
The failure of SHNef and HSNef to downregulate CD4
surface expression and bind MW  62,000 and 78,000
phosphoproteins cannot be explained by protein instabil-
ity. SHNef and HSNef were expressed at levels compara-
FIG. 4. Analysis of human CD4 cell surface expression in CEM cells ble to SNef or the SHSNef hybrid (Fig. 2). The observed
expressing Nef hybrids. Control cells (LXSN) and cells expressing stability of SHNef and HSNef may result from the fact
Nef, SNef, and their three chimeras were analyzed for cell surface
that only amino acids 75 to 207 of Nef fold into a definedexpression with human CD4-specific monoclonal antibodies conju-
structure (Lee et al., 1996 and Grzesiek et al., 1996). Asgated to PE. The dashed line represents background fluorescence
from cells incubated with isotype-matched PE-conjugated control anti- a result, substitution of an extended segment at the N-
body (top panel). LXSN, control cells not expressing Nef; Nef, cells terminus may not disrupt overall structure.
expressing HIVSF2Nef; SNef, cells expressing SIV Nef; SHS, cells ex- The possibility that the junction of SNef and Nef se-
pressing SHSNef; HS, cells expressing HSNef; SH, cells expressing
quences in SHNef and HSNef creates a specific func-SHNef.
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FIG. 5. Nef-associated phosphoproteins in human T-cells. (A) Lysates from control CEM cells (LXSN) and HIVSF2Nef expressing cells were
immunoadsorbed with Nef-specific antibodies. Immunoprecipitates were assayed for protein kinase activity as described in Sawai et al. (1994).
Phosphoproteins were detected by autoradiography. (B) Lysates from control CEM cells (LXSN) and cells expressing SHSNef and HSNef were
immunoadsorbed with HIV-1 Nef-specific antibodies and assayed for protein kinase activity (first three lanes). Lysates from control CEM cells
(LXSN) and cells expressing SNef and SHNef were immunoadsorbed with SIV Nef-specific antibodies and assayed for protein kinase activity (last
three lanes). Phosphorylated proteins were detected by autoradiography.
tional disruption in the abilities of these proteins to down- ing a defined fold are necessary for CD4 downregulation
and the association with a cellular protein kinase. Inregulate CD4 is unlikely. The location of the junction
resides in the (PXX)4 region which is highly conserved, future studies it will be important to correlate the various
Nef functions to Nef structure and determine how theseand which Goldsmith et al. (1995) have shown to be
unessential for the downregulation of CD4. Thus, despite functions relate to each other and viral pathogenesis.
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